Table 2. Partner disclosure patterns and associations with treatment and MTCT outcomes.
| Mother not on ARTa | Suboptimal treatment adherenceb | Mother to Child Transmission at 4–26 weeks |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n/Nc | % | aOR (95% CI)f | p-value | n/Nc | % | aOR (95% CI)f | p-value | n/Nc | % | aOR (95% CI) g | p-value | |
| All | 100/3153 | 3.2 | 318/3027 | 10.5 | 95/3153 | 3 | ||||||
| Marital status | ||||||||||||
| Mothers with spouse/cohabiting partner | 84/2882 | 2.9 | - | 283/2779 | 10.2 | - | 81/2882 | 2.8 | - | |||
| Mothers without a partner | 16/265 | 6 | 2.4 (1.3–4.2) | 0.003 | 34/246 | 13.8 | 1.4 (0.9–2.0) | 0.11 | 13/265 | 4.9 | 1.7 (0.9–3.1) | 0.09 |
| Missing | 6-Jan | 16.7 | 0/2 | 0 | 6-Jan | 16.7 | ||||||
| Mother disclosure, among those with partner | ||||||||||||
| Mother disclosed HIV-positive status to male partner | 62/2696 | 2.3 | - | 265/2615 | 9.8 | - | 67/2696 | 2.5 | - | |||
| Mother did not disclose her status to male partner | 20/186 | 10.8 | 3.6 (2.1–6.4) | 0.0001 | 27/164 | 16.5 | 1.6 (1.0–2.4) | 0.05 | 14/186 | 7.5 | 2.4 (1.3–4.4) | 0.007 |
| Partner disclosure, among mothers with partner | ||||||||||||
| Partner disclosed HIV status (any) to motherd | 38/2107 | 1.8 | - | 175/2053 | 8.5 | - | 55/2107 | 2.6 | - | |||
| Partner did not disclosee | 45/774 | 5.8 | 2.8 (1.5–5.2) | 0.0001 | 109/725 | 15 | 1.8 (1.4–2.3) | 0.001 | 27/774 | 3.5 | 1.1 (0.7–1.8) | 0.76 |
| Missing | 0/1 | 0 | 0/0 | 0 | 0/1 | 0 | ||||||
| Partner’s HIV status | ||||||||||||
| Partner reported HIV positive | 24/1491 | 1.6 | - | 128/1454 | 8.8 | - | 34/1491 | 2.3 | - | |||
| Partner reported HIV negative | 14/616 | 2.3 | 1.5 (0.8–3.0) | 0.25 | 46/599 | 7.7 | 0.9 (0.6–1.2) | 0.45 | 20/616 | 3.2 | 1.4 (0.8–2.4) | 0.25 |
| HIV-status of partner unknown | 45/774 | 5.8 | 3.2 (1.9–5.4) | 0.001 | 109/725 | 15 | 1.7 (1.3–2.2) | 0.001 | 27/774 | 3.5 | 1.2 (0.7–2.1) | 0.44 |
| Missing | 0/1 | 0 | 0/1 | 0 | 0/1 | 0 | ||||||
| Disclosure between partners | ||||||||||||
| Both partners disclosed (any status) | 36/2090 | 1.7 | - | 171/2038 | 8.4 | - | 52/2090 | 2.5 | - | |||
| One partner disclosed (any status) | 29/622 | 4.7 | 2.5 (1.5–4.2) | 0.001 | 88/591 | 14.9 | 1.8 (1.4–2.4) | 0.001 | 17/622 | 2.7 | 0.9 (0.5–1.6) | 0.76 |
| Neither of the partners disclosed | 18/169 | 10.7 | 4.7 (2.5–8.8) | 0.0001 | 24/149 | 16.1 | 1.8 (1.1–2.8) | 0.02 | 12/169 | 7.1 | 2.1 (1.1–4.1) | 0.04 |
| Missing | 0/1 | 0 | 0/1 | 0 | 0/1 | 0 | ||||||
ART: antiretroviral therapy
aOR: adjusted odds ratio
CI: confidence interval
a Did not start, stopped or did not want to reveal
b Missed at least two days of antiretroviral medication in the last month
c Numerator/Denominator
d Mother reported to know the result of HIV test ever taken by partner
e Mother reported that partner never had an HIV test or did not know whether he ever had
f Mother reported that partner never had an HIV test or did not know whether he ever had
gAdjusted for geographical region, age, parity, time from when mother knew her HIV-positive status, and uptake of maternal ART and infant nevirapine prophylaxis